ArticleOncoTargets and therapy2018

miR-185 suppresses progression of Ewing's sarcoma via inhibiting the PI3K/AKT and Wnt/β-catenin pathways.

Shuai Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.